PT Merck Tbk (PT Merck Tbk) Debt-to-Asset : 0.02 (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is PT Merck Tbk Debt-to-Asset?

PT Merck Tbk's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.40 Mil. PT Merck Tbk's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.93 Mil. PT Merck Tbk's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Mar. 2024 was $69.24 Mil. PT Merck Tbk's debt to asset for the quarter that ended in Mar. 2024 was 0.02.

PT Merck Tbk Debt-to-Asset Historical Data

The historical data trend for PT Merck Tbk's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Merck Tbk Debt-to-Asset Chart

PT Merck Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.02

PT Merck Tbk Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Asset	Get a 7-Day Free Trial															0.01	0.02	0.02	0.02	0.02

Competitive Comparison of PT Merck Tbk's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, PT Merck Tbk's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT Merck Tbk's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PT Merck Tbk's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where PT Merck Tbk's Debt-to-Asset falls into.

PT Merck Tbk Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

PT Merck Tbk's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.45	+	0.726)	/	62.131
	=	0.02

PT Merck Tbk's Debt-to-Asset for the quarter that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.404	+	0.926)	/	69.236
	=	0.02

PT Merck Tbk (GREY:PMKIF) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

PT Merck Tbk Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of PT Merck Tbk's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Merck Tbk (PT Merck Tbk) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PT Merck Tbk (GREY:PMKIF) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

MERK:Indonesia

Address

Jalan T.B. Simatupang No. 8, Pasar Rebo, Jakarta Timur, IDN, 13760

Website

https://www.merck.co.id

PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia. The company operates in three segments: Biopharma, Consumer Health, and Others. The company offers pharmaceutical and biological prescription medicines to treat cancer, multiple sclerosis, infertility, growth disorders, and cardiovascular and metabolic diseases, as well as chronic diseases.

PT Merck Tbk (PT Merck Tbk) Headlines

No Headlines